Proteomics

Dataset Information

0

A 6-Month Systems Toxicology Inhalation/Cessation Study in ApoE-/- Mice to Investigate Cardiovascular and Respiratory Exposure Effects of the Modified-Risk Tobacco Products CHTP1.2 and THS2.2 Compared with the Effects of Conventional Cigarettes [Heart iTRAQ data].


ABSTRACT: Cigarette smoke (CS) causes adverse health effects that may occur shortly after smoking initiation and lead to the development of respiratory disease (chronic obstructive pulmonary disease), cardiovascular disease, and cancer. To reduce the risk of smokers developing smoking-related diseases, Philip Morris International is developing modified risk tobacco products (MRTP). Within a systems toxicology study, we integrated multi-omics measurements with classical endpoints to assess the effects in female ApoE-/- mice of six months of exposure to CS (at 29.9 µg nicotine/L) or to aerosols from one potential and one candidate MRTP (CHTP 1.2 and THS 2.2, respectively) at matched nicotine concentrations. The impact of cessation or switching to CHTP 1.2 after three months of CS exposure was also evaluated. This data set contains the results from the analysis of proteome changes in the heart using the iTRAQ® quantification approach.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Heart

SUBMITTER: Bjoern Titz  

LAB HEAD: Julia Hoeng

PROVIDER: PXD010873 | Pride | 2022-02-23

REPOSITORIES: Pride

Similar Datasets

2019-06-18 | PXD010875 | Pride
2022-02-23 | PXD010874 | Pride
2018-03-19 | PXD008423 | Pride
2018-03-19 | PXD008422 | Pride
2018-03-19 | PXD008424 | Pride
2019-04-18 | E-MTAB-7444 | biostudies-arrayexpress
2019-04-18 | E-MTAB-7892 | biostudies-arrayexpress
2015-11-30 | PXD002530 | Pride
2021-03-16 | E-MTAB-9248 | biostudies-arrayexpress
2016-01-04 | PXD001369 | Pride